CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- 4 Open-market sale Director sold 10,200 shares at $27.22 ($277,644)
- 4 Planned sale Chief Technology Officer sold 4,887 shares at $26.96 ($131,754)
- 4 Planned sale Chief Technology Officer sold 4,887 shares at $24.38 ($119,145)
- 4 Planned sale President and CEO sold 20,846 shares at $25.03 ($521,775)
- 4 Planned sale Chief Financial Officer sold 846 shares at $25.00 ($21,150)
- 4 Planned sale Senior VP, Finance and PAO sold 9,255 shares at an average $24.25 ($224,451)
- 4 Planned sale Chief Technology Officer sold 4,887 shares at $24.33 ($118,901)
- 4 Planned sale President and CEO sold 39,540 shares at $24.61 ($973,079)
- 4 Planned sale Chief Financial Officer sold 652 shares at $25.00 ($16,300)
- 4 Open-market sale Chief Revenue Officer sold 1,361 shares at $24.02 ($32,691)
- 4 Planned sale Senior VP, Finance and PAO sold 1,852 shares at an average $23.99 ($44,425)
- 4 Open-market sale Chief Technology Officer sold 1,979 shares at $24.02 ($47,536)
- 4 Open-market sale Chief Financial Officer sold 1,521 shares at $24.02 ($36,534)
- 4 Open-market sale President and CEO sold 6,068 shares at $24.02 ($145,753)
- 4 Planned sale Chief Financial Officer sold 34,502 shares at an average $25.03 ($863,555)
- 4/A Derivatives Options or other derivatives
- 4 Planned sale President and CEO sold 33,614 shares at an average $25.03 ($841,292)
- 4 Option exercise President and CEO acquired 33,096 shares (option exercise)
- 4 Open-market sale Director sold 13,095 shares at $23.40 ($306,423)
- 4 Planned sale President and CEO sold 39,000 shares at $18.32 ($714,480)
Page 1 of 7 · 134 filings